Granulocyte transfusion therapy for life-threatening bacteremia: results of transfusion trials at the National Cancer Institute.
D000380:Agranulocytosis / Q000150:complications / Q000628:therapy; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001771:Blood Banks; D001803:Blood Transfusion; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006098:Granulocytes / Q000637:transplantation*; D006680:HLA Antigens / Q000145:classification; D006650:Histocompatibility Testing; D006801:Humans; D007937:Leukapheresis; D017708:Leukocyte Transfusion; D009503:Neutropenia / Q000150:complications / Q000628:therapy; D009504:Neutrophils / Q000637:transplantation; D018805:Sepsis / Q000150:complications / Q000209:etiology / Q000628:therapy*
D000900:Anti-Bacterial Agents; D006680:HLA Antigens